hit counter

Chlorpyrifos Exposure Linked to Up to 174% Higher Parkinson’s Risk

MHD featured image for chlorpyrifos exposure, Parkinson's risk, dopaminergic neurons, and autophagy dysfunction.

A human, mouse, and zebrafish study linked long-term chlorpyrifos exposure to Parkinson’s disease risk, with the strongest exposure-duration estimate reaching OR 2.74 for workplace proximity across the 1974-to-index-year window.1 The paper is stronger than a single epidemiology result because animal experiments pointed to dopaminergic neuron loss, microglial activation, pathological α-synuclein, and autophagy dysfunction. Research Highlights …

Read more

Early-Life Visceral Stress Sensitized Auditory Brainstem Responses in Rats

MHD featured image for early-life visceral stress and auditory brainstem sensitization.

A 40-rat early-life visceral stress study found auditory pathway sensitization without hearing-threshold loss: neonatal colorectal distension produced IBS-like visceral hypersensitivity, normal ABR thresholds, shortened auditory brainstem latencies, increased amplitudes, and 219 differentially expressed cochlear proteins.1 The result turns IBS-like stress exposure into a gut-pain and sensory-processing question. Research Highlights Visceral hypersensitivity was strong: At 20 …

Read more

Traumatic Injury and Depression Show Oxytocin Methylation Signal

MHD featured image for traumatic injury, depression, and oxytocin-pathway methylation.

A 2026 Generation Scotland study linked traumatic physical injury to diagnosis-stratified blood methylation differences in 4,308 people.1 The clearest recurrent-depression signal pointed toward oxytocin signaling and synaptic-plasticity pathways, but the result is still exploratory pathway evidence rather than a blood test for depression or PTSD. Research Highlights Recurrent depression carried the strongest phenotype signal: traumatic …

Read more

Alzheimer’s PET Imaging Now Gates Anti-Amyloid Therapy Eligibility

MHD featured image for Alzheimer's PET imaging and anti-amyloid therapy eligibility.

A 2026 review in the Japanese Journal of Radiology argued that amyloid PET has moved from an optional Alzheimer’s disease biomarker to a practical eligibility gate for anti-amyloid antibody therapy, while tau PET and FDG-PET answer different questions in the same clinical workflow.1 The key shift is not that every memory complaint needs PET; it …

Read more

Electroacupuncture for Depression Has Mechanisms, Not Firm Trial Proof

MHD featured image for electroacupuncture depression mechanisms and clinical evidence.

A 2026 review of electroacupuncture for depression found a familiar split: mechanistic evidence is rich, but clinical proof remains uneven because representative trials ranged from 65 to 270 participants, used different sham or drug comparators, and often failed to connect stimulation parameters with biological endpoints.1 Electroacupuncture is plausible as a subtype-matched neuromodulation strategy, but it …

Read more

Early Antidepressants Linked to Bipolar Impulsivity During Euthymia

MHD featured image for early antidepressant exposure and impulsivity in bipolar disorder.

A 124-person study of euthymic bipolar disorder found that patients with early systematic antidepressant treatment history had higher negative affect, attentional impulsivity, non-planning impulsivity, and total BIS-11A impulsivity scores than matched patients without that history.1 The association is clinically cautionary, but the cross-sectional design cannot separate antidepressant effects from delayed bipolar diagnosis or more severe …

Read more

COPE-A Reduced Youth PTSD in Substance-Use Trial

MHD featured image for youth PTSD, substance use, COPE-A, and symptom sequencing during therapy.

A 2026 randomized youth trial found that integrated exposure-based treatment reduced posttraumatic stress disorder symptoms more than supportive counseling, while substance-use changes were smaller and showed no clear treatment-specific advantage. Research Highlights COPE-A reduced PTSD more: youth receiving Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure – Adolescent version had a 17.00-point …

Read more